Drug or chemical induced diabetes mellitus with kidney complications
ICD-10 E09.2 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with kidney complications.
Drug or chemical induced diabetes mellitus is a form of diabetes that arises as a result of exposure to certain medications or chemicals that affect insulin secretion or action. This condition can lead to significant metabolic disturbances, including hyperglycemia. When kidney complications are present, it indicates that the diabetes has progressed to affect renal function, potentially leading to diabetic nephropathy. Patients may present with elevated blood glucose levels and increased HbA1c, which reflects long-term glucose control. Management often involves insulin therapy, oral hypoglycemic agents, and careful monitoring of renal function. The presence of kidney complications necessitates a multidisciplinary approach to care, including nephrology consultation, to prevent further deterioration of kidney function and manage associated complications such as hypertension and electrolyte imbalances.
Detailed medication history, HbA1c levels, and renal function tests.
Patients presenting with hyperglycemia after starting new medications.
Endocrinologists must ensure clear documentation of the relationship between drug exposure and diabetes onset.
Assessment of kidney function, including GFR and proteinuria levels.
Patients with diabetes presenting with worsening renal function.
Nephrologists should document the impact of diabetes on renal health and any interventions undertaken.
Used to monitor long-term glucose control in patients with drug-induced diabetes.
Document the date of the test and results in the patient's medical record.
Endocrinologists should correlate HbA1c results with medication history.
Medications such as corticosteroids, certain antipsychotics, and thiazide diuretics are known to potentially induce diabetes by affecting insulin secretion or action.
